Effects of regenerative agents injection in knee osteoarthrosis
Phase 2
- Conditions
- knee osteoarthrosis.Primary unilateral knee arthrosis
- Registration Number
- IRCT2014101810599N2
- Lead Sponsor
- Vice chancellor for research- Iran University of Medical Sciences-
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Knee osteoarthritis stage I-III according to American Rheumatologist society criteria or radiologic criteria I-III according to Kalgreen-Lawrence criteria, 40-70 years age.
Exclusion criteria: addiction to opioids or alcohol, history of rheumatoid arthritis or any rheumatologic disease, hemophilia
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain score. Timepoint: Before performing the intervention (0) and 1, 4 & 8 weeks after performing the intervention. Method of measurement: Visual analogue scale with specialized ruler and recording in questionnaire.;Knee range of motion. Timepoint: Before performing the intervention (0) and 1, 4 & 8 weeks after performing the intervention. Method of measurement: Using goniometer and recording in questionnaire.
- Secondary Outcome Measures
Name Time Method Pain killer number. Timepoint: Before performing the intervention (0) and 1, 4 & 8 weeks after performing the intervention. Method of measurement: number of pain killer usage and record in questionnaire.